跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EZETIMIBA/ATORVASTATINA OLPHA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
EZETIMIBA/ATORVASTATINA OLPHA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG
Approved
STANDARD
EZETIMIBA/ATORVASTATINA OLPHA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG
Olpha As
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 5, 2024
Approval ID
a512d54d9074fffb
Company
Olpha As
Type
Standard
Approval Details
Approval Id
a512d54d9074fffb
Drug Cima Aemps Name
EZETIMIBA/ATORVASTATINA OLPHA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG
Register Number
89279
Holder Company Name
Olpha As
Marketing Company Name
Olpha As
Authorization Date
2024-02-05
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
10 mg/10 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Olpha As
Active Ingredients
EZETIMIBA
10 mg
ATORVASTATINA CALCICA TRIHIDRATO
10,825 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 5, 2024
Approval ID
a512d54d9074fffb
Type
Standard
Back to CIMA-AEMPS Approvals